3',4'-dihydroxyflavone has been researched along with isoliquiritigenin in 2 studies
Studies (3',4'-dihydroxyflavone) | Trials (3',4'-dihydroxyflavone) | Recent Studies (post-2010) (3',4'-dihydroxyflavone) | Studies (isoliquiritigenin) | Trials (isoliquiritigenin) | Recent Studies (post-2010) (isoliquiritigenin) |
---|---|---|---|---|---|
31 | 0 | 14 | 472 | 2 | 324 |
Protein | Taxonomy | 3',4'-dihydroxyflavone (IC50) | isoliquiritigenin (IC50) |
---|---|---|---|
Estrogen receptor | Homo sapiens (human) | 1.87 | |
Interstitial collagenase | Homo sapiens (human) | 0.016 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.269 | |
72 kDa type IV collagenase | Homo sapiens (human) | 0.01 | |
Stromelysin-1 | Homo sapiens (human) | 0.081 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.269 | |
Matrilysin | Homo sapiens (human) | 0.008 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.269 | |
Aromatase | Homo sapiens (human) | 3.8 | |
17-beta-hydroxysteroid dehydrogenase type 1 | Homo sapiens (human) | 2.83 | |
Matrix metalloproteinase-9 | Homo sapiens (human) | 0.01 | |
Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 0.32 | |
Proteasome subunit beta type-5 | Homo sapiens (human) | 4.88 | |
17-beta-hydroxysteroid dehydrogenase type 2 | Homo sapiens (human) | 0.36 | |
Collagenase 3 | Homo sapiens (human) | 0.014 | |
Estrogen receptor beta | Homo sapiens (human) | 0.269 | |
NACHT, LRR and PYD domains-containing protein 3 | Homo sapiens (human) | 1.54 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gavande, N; Hanrahan, JR; Hibbs, DE; Kim, MS; Matin, A; Roubin, RH; Salam, NK; Yang, NX | 1 |
Kogami, Y; Matsuda, H; Nakamura, S; Sugiyama, T; Ueno, T; Yoshikawa, M | 1 |
2 other study(ies) available for 3',4'-dihydroxyflavone and isoliquiritigenin
Article | Year |
---|---|
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
Topics: Benzopyrans; Cell Line; Humans; PPAR alpha; PPAR gamma; Structure-Activity Relationship | 2009 |
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
Topics: 3T3-L1 Cells; Adipogenesis; Animals; CCAAT-Enhancer-Binding Protein-alpha; CCAAT-Enhancer-Binding Protein-beta; CCAAT-Enhancer-Binding Protein-delta; Deoxyglucose; Fatty Acid-Binding Proteins; Flavonoids; Glucose Transporter Type 4; Mice; PPAR gamma; Structure-Activity Relationship | 2011 |